Aileron Therapeutics Inc. is a clinical-stage biopharmaceutical company that is focused on enabling patients to fight cancer without the fear or burden of chemotherapy-induced side effects. The company believes selective chemoprotection has the potential to fundamentally transform chemotherapy like anesthesia transformed surgery.